Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment

BACKGROUND: To investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal cancer (mCRC) patients with long-term efficacy from regorafenib treatment. METHODS: Retrospective, single institution analysis of patients with chemorefractory mCRC treated with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinelli, Erika, Sforza, Vincenzo, Cardone, Claudia, Capasso, Anna, Nappi, Anna, Martini, Giulia, Napolitano, Stefania, Rachiglio, Anna Maria, Normanno, Nicola, Cappabianca, Salvatore, Reginelli, Alfonso, Bisceglie, Maurizio Di, Latiano, Tiziana Pia, Maiello, Evaristo, Orditura, Michele, Vita, Fernando De, Morgillo, Floriana, Ciardiello, Fortunato, Troiani, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESMO Open 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703385/
https://www.ncbi.nlm.nih.gov/pubmed/29211816
http://dx.doi.org/10.1136/esmoopen-2017-000177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703385/
https://www.ncbi.nlm.nih.gov/pubmed/29211816
http://dx.doi.org/10.1136/esmoopen-2017-000177

Ejemplares similares